Sustained delivery of therapeutics to the visual system using genetically modified autologous mesenchymal stem cells to treat blinding diseases
使用转基因自体间充质干细胞向视觉系统持续输送治疗药物来治疗致盲疾病
基本信息
- 批准号:10395474
- 负责人:
- 金额:$ 36.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAffectAftercareAutologousBehaviorBiochemicalBiological MarkersBlindnessBone MarrowBrainCLN2 geneCNS degenerationCanis familiarisCellsCerebrospinal FluidChildChildhoodClinical TrialsCognitiveControl GroupsDiseaseDisease ProgressionDisease modelElectroretinographyEnzymesExhibitsEyeHumanImplantIndividualInfusion proceduresInjectionsLocationLongevityMediatingMesenchymal Stem CellsMethodsMonitorMotorMutationNerve DegenerationNervous System PhysiologyNeuraxisNeuronal Ceroid-LipofuscinosisPathologyPatientsPatternPeriodicityPersonsProteinsRecombinantsResearchRetinaRetinal DegenerationSafetySeizuresSolidStructureTabletsTestingTherapeuticTimeTissuesTreatment EfficacyTreatment ProtocolsVisionVisualVisual PathwaysVisual impairmentVisual system structurebasebiomarker panelcanine modelcerebral atrophycognitive functionenzyme replacement therapyimplantationintravitreal injectionnervous system disordernovelpreservationpreventprotein biomarkersprototypesignal processingstem cell therapytherapeutic enzymetherapeutic proteintreatment effecttreatment grouptripeptidyl aminopeptidaseuptakevisual processing
项目摘要
PROJECT SUMMARY
The objective of the proposed research is to evaluate the safety and efficacy of a novel method of delivering
therapeutics to the central nervous system (CNS) and the retina to treat diseases associated with visual
impairment. The hypothesis tested will be that autologous genetically modified mesenchymal stem cells
(MSCs) can serve as effective vehicles for sustained delivery of therapeutics to visual centers in the brain and
to the retina for the treatment of blinding diseases that result from pathology in one or more parts of the visual
system. Proof of concept studies will be performed using a well-characterized and validated canine model of
CLN2 neuronal ceroid lipofuscinosis, a disease with pediatric onset characterized by widespread
neurodegeneration resulting in progressive loss of vision due to degeneration of both the retina and visual
processing centers in the brain, cognitive and motor decline, and seizures. CLN2 disease is caused by
mutations in TPP1, which result in deficiencies of the soluble lysosomal enzyme tripeptidyl peptidase-1 (TPP1).
It is hypothesized that providing TPP1 to the CNS using implantation of autologous MSCs that have been
genetically modified to produce and secrete the protein will ameliorate disease-related vision loss in the canine
model. To test this hypothesis, TPP1-producing MSCs will be injected into the vitreous of the eye and into the
cerebrospinal fluid (CSF) of dogs affected by CLN2 disease. Based on previous studies, significant transfer of
TPP1 from cells implanted in these locations to the retina and brain are anticipated, respectively. Functional
vision will be evaluated in treated dogs using a novel iPad tablet based test that requires a choice between a
screen displaying solid grey and a screen displaying a black and white stripe / grating pattern. Retinal function
will be assessed with electroretinography, and retina-CNS interactions will be assessed with quantitative
pupillometry. Dogs will also be monitored with established biomarkers of disease progression to determine if
implantation of TPP1-producing MSCs results in amelioration of the neurological disease signs not directly
associated with vision, preserves cognitive function, inhibits brain atrophy, and extends healthy lifespan when
compared with control dogs. In addition, assessed will be the safety, persistence, and distribution of the
implanted MSCs and the TPP1 enzyme they produce through histopathologic and immunohistochemical
analysis of CNS tissues. Successful accomplishment of these aims will set the groundwork for testing this
approach to therapy in children suffering from CLN2 disease and similar lysosomal storage disorders. It will
also serve as the prototype for adopting this approach to treat many other diseases affecting the CNS and
retina.
项目摘要
这项研究的目的是评估一种新的给药方法的安全性和有效性。
用于治疗与视觉相关的疾病的中枢神经系统(CNS)和视网膜的治疗剂
损伤所检验的假设是自体遗传修饰的间充质干细胞
骨髓间充质干细胞(MSC)可以作为有效的载体,用于将治疗剂持续递送至大脑中的视觉中心,
用于治疗致盲性疾病,所述致盲性疾病是由视觉系统的一个或多个部分的病理引起的。
系统将使用充分表征和验证的犬模型进行概念验证研究,
CLN 2神经元蜡样质脂褐质沉积症,一种儿科发病的疾病,其特征在于广泛的
神经变性导致由于视网膜和视觉系统的变性而导致视力的进行性丧失,
大脑中的处理中心,认知和运动能力下降,以及癫痫发作。CLN 2疾病是由
TPP 1突变,导致可溶性溶酶体酶三肽基肽酶-1(TPP 1)缺乏。
假设通过植入自体骨髓间充质干细胞向CNS提供TPP 1,
一种经过基因改造,能够产生和分泌这种蛋白质的动物,
模型为了检验这一假设,将产生TPP 1的MSC注射到眼睛的玻璃体中,并注射到眼内。
受CLN 2疾病影响的狗的脑脊液(CSF)。根据以往的研究,
TPP 1从植入这些位置的细胞分别到视网膜和大脑。功能
将使用一种基于iPad平板电脑的新型测试对治疗犬的视力进行评估,该测试需要在以下两种方法之间进行选择:
显示纯灰色的屏幕和显示黑色和白色条纹/光栅图案的屏幕。视网膜功能
将用视网膜电图评估,视网膜-CNS相互作用将用定量
瞳孔测量法还将使用已确定的疾病进展生物标志物监测犬,以确定是否
植入产生TPP 1的MSC导致神经系统疾病体征的改善,
与视力相关,保留认知功能,抑制脑萎缩,并延长健康寿命,
与对照犬相比。此外,还将评估药物的安全性、持久性和分布。
通过组织病理学和免疫组织化学观察移植的MSC及其产生的TPP 1酶
CNS组织的分析。这些目标的成功实现将为测试这一点奠定基础。
在患有CLN 2疾病和类似溶酶体贮积症的儿童中的治疗方法。它将
也可以作为采用这种方法治疗许多其他影响CNS的疾病的原型,
视网膜。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rebecca EH Whiting其他文献
Rebecca EH Whiting的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rebecca EH Whiting', 18)}}的其他基金
Sustained delivery of therapeutics to the visual system using genetically modified autologous mesenchymal stem cells to treat blinding diseases
使用转基因自体间充质干细胞向视觉系统持续输送治疗药物来治疗致盲疾病
- 批准号:
9919579 - 财政年份:2019
- 资助金额:
$ 36.57万 - 项目类别:
Sustained delivery of therapeutics to the visual system using genetically modified autologous mesenchymal stem cells to treat blinding diseases
使用转基因自体间充质干细胞向视觉系统持续输送治疗药物来治疗致盲疾病
- 批准号:
10615615 - 财政年份:2019
- 资助金额:
$ 36.57万 - 项目类别:
Sustained delivery of therapeutics to the visual system using genetically modified autologous mesenchymal stem cells to treat blinding diseases
使用转基因自体间充质干细胞向视觉系统持续输送治疗药物来治疗致盲疾病
- 批准号:
10723142 - 财政年份:2019
- 资助金额:
$ 36.57万 - 项目类别:
Sustained delivery of therapeutics to the visual system using genetically modified autologous mesenchymal stem cells to treat blinding diseases
使用转基因自体间充质干细胞向视觉系统持续输送治疗药物来治疗致盲疾病
- 批准号:
9982477 - 财政年份:2019
- 资助金额:
$ 36.57万 - 项目类别:
Sustained delivery of therapeutics to the visual system using genetically modified autologous mesenchymal stem cells to treat blinding diseases
使用转基因自体间充质干细胞向视觉系统持续输送治疗药物来治疗致盲疾病
- 批准号:
10558256 - 财政年份:2019
- 资助金额:
$ 36.57万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 36.57万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 36.57万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 36.57万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 36.57万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 36.57万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 36.57万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 36.57万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 36.57万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 36.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 36.57万 - 项目类别:
Studentship